Flow CAST®: Research Use Only in the US. Not for diagnostic procedures. Health Canada License:101781 BÜHLMANN Flow CAST® and Basophil Activation (BAT): Basophil Activation Tests (BAT) have been extensively studied as in vitro functional assays and have demonstrated superior accuracy as compared to other blood tests for various allergies (1). BÜHLMANN provides a broad range of
Continue Reading
Tag: basophil activation test
Download eBOOK Webinar Recording Webinar Overview Abstract The basophil activation test has emerged as a novel diagnostic test for food allergy. Being a functional test, it has the potential to closely resemble the clinical phenotype of patients following allergen exposure. The basophil activation test can be seen as an in vitro challenge, where instead of
Continue Reading
AMLI 2017 BUHLMANN Diagnostics Corp Booth: #13 August 13 - 16, 2017 Renaissance Stapleton Hotel | Denver, C0 LEARN MORE Click & Contact our AMLI 2017BUHLMANN Team Connect with our team ahead of time, learn more about the BÜHLMANN's Products and Solutions or schedule a meeting! Jennifer Stuart, Technical Sales Specialist JENNIFER STUART Technical Sales Specialist jls@buhlmannlabs.com
Continue Reading
BÜHLMANN’s Kinase Inhibition Assay Testing Potency and Efficacy of Inhibitors of PI3K δ, PI3K γ, BTK and SYK Activity Biomarker assays are developed specifically for pharmacokinetic and pharmacodyamic (PK/PD) models during drug discovery and are often used to test efficacy and toxicity. Inhibitors of PI3K, BTK and SYK pathways are a large focus for pharmaceutical
Continue Reading
We are pleased to announce 2 new BÜHLMANN CAST® Drug Allergens: Tramadol and Metoprolol In order to meet the needs of your Cellular Allergy testing, we are offering an extended allergen portfolio by enriching this product line with new Analgesic and Beta Blocker allergens. Tramadol and Metroprolol are for Research Use Only. Not for use in diagnostic procedures.
Continue Reading
Flow CAST® eBook Testing Potency and Efficacy of Inhibitors of PI3K, PI3K, BTK and SYK Activity Biomarker assays are developed specifically for pharmacokinetic and pharmacodyamic (PK/PD) models during drug discovery and are often used to test efficacy and toxicity. Inhibitors of PI3K, SYK and BTK pathways are a large focus for pharmaceutical companies with several
Continue Reading
